Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer
Abstract Introduction Tyrosine kinase inhibitors, including lenvatinib approved for advanced non-medullary thyroid cancer (TC), affect the immune system. As tumor-related inflammation contributes to TC pathogenesis, this study assesses the immunomodulatory effects of lenvatinib, focusing on myeloid...
में बचाया:
| मुख्य लेखकों: | , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Springer
2025-12-01
|
| श्रृंखला: | Cancer Immunology, Immunotherapy |
| विषय: | |
| ऑनलाइन पहुंच: | https://doi.org/10.1007/s00262-025-04241-7 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|